Loss of metabolic adaptation in lean MAFLD is driven by endotoxemia leading to epigenetic reprogramming
{{output}}
Lean patients with MAFLD have an initial adaptive metabolic response characterised by increased serum bile acids and Farnesoid X Receptor (FXR) activity. How this adaptive response wanes resulting in an equal or perhaps worse long-term adverse outcome compared... ...
